Skip to content
Triangle logo TriangleGet started
← Childhood Acute Lymphoblastic Leukemia

HEALTH PROFESSIONAL · SOURCE READING

Intrathecal medication after HSCT to prevent relapse

Source: Childhood Acute Lymphoblastic Leukemia Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: April 21, 2025 · Captured 2026-09-09.

Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.

Context: Treatment of Relapsed Childhood ALL / Hematopoietic Stem Cell Transplant for First and Subsequent Bone Marrow Relapse

The use of post-HSCT intrathecal chemotherapy chemoprophylaxis is controversial.[144-147]

Source links and citations

Publication references

Read the original reference and check its publication notices.

Preserved source evidence · Not medical advice